Overexpression of MiR-130a-3p/301a-3p Attenuates High Glucose-induced MPC5 Podocyte Dysfunction Through Suppression of TNF-α Signaling
Overview
Affiliations
Tumor necrosis factor (TNF)-α has been reported to be important in glomerulonephritis, which is closely associated with podocyte dysfunction and apoptosis. However, the precise mechanisms by which TNF-α expression are regulated remain unclear. The purpose of the present study was to investigate the role of microRNA (miR)-130a-3p/301a-3p in the post-transcriptional control of TNF-α expression and high glucose (HG)-induced podocyte dysfunction. Mice MPC5 podocytes were incubated with HG and transfected with miR-130a-3p/301a-3p mimics or inhibitors, reactive oxygen species (ROS) levels were measured by flow cytometry assay, and the mRNA and protein levels were assayed by using reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. The targeted genes were predicted by a bioinformatics algorithm and verified using a dual luciferase reporter assay. It was observed that miR-130a-3p/301a-3p was a novel regulator of TNF-α in mouse podocytes. miR-130a-3p/301a-3p mimics inhibited TNF-α 3'-untranslated region luciferase reporter activity, in addition to endogenous TNF-α protein expression. Furthermore, forced expression of miR-130a-3p or miR-301a-3p resulted in the downregulation of ROS and malondialdehyde (MDA) and the upregulation of superoxide dismutase (SOD) 1 in the presence of HG. Inhibition of TNF-α level prevented a remarkable reduction in SOD activity and a marked increase in ROS and MDA levels in HG-treated podocytes. Furthermore, TNF-α loss-of-function significantly reversed HG-induced podocyte apoptosis. These data demonstrated a novel up-stream role for miR-130a-3p/301a-3p in TNF-α-mediated podocyte dysfunction and apoptosis in the presence of HG.
Barilani M, Peli V, Manzini P, Pistoni C, Rusconi F, Pinatel E Int J Biol Sci. 2024; 20(15):6255-6278.
PMID: 39664576 PMC: 11628337. DOI: 10.7150/ijbs.100113.
Barreiro K, Dwivedi O, Rannikko A, Holthofer H, Tuomi T, Groop P Genes (Basel). 2023; 14(7).
PMID: 37510317 PMC: 10379145. DOI: 10.3390/genes14071415.
Jamalpour S, Zain S, Vazifehmand R, Mohamed Z, Pung Y, Kamyab H Sci Rep. 2022; 12(1):20295.
PMID: 36434110 PMC: 9700700. DOI: 10.1038/s41598-022-23816-3.
MicroRNAs in Podocyte Injury in Diabetic Nephropathy.
Ishii H, Kaneko S, Yanai K, Aomatsu A, Hirai K, Ookawara S Front Genet. 2020; 11:993.
PMID: 33193581 PMC: 7477342. DOI: 10.3389/fgene.2020.00993.
The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress.
Wlodarski A, Strycharz J, Wroblewski A, Kasznicki J, Drzewoski J, Sliwinska A Int J Mol Sci. 2020; 21(18).
PMID: 32962281 PMC: 7555602. DOI: 10.3390/ijms21186902.